Breaking News Instant updates and real-time market news.

RCL

Royal Caribbean

$104.31

0.42 (0.40%)

, NCLH

Norwegian Cruise Line

$45.72

0.72 (1.60%)

07:35
01/10/19
01/10
07:35
01/10/19
07:35

JPMorgan says stay long Royal Caribbean, Norwegian on 'depressed' valuations

JPMorgan analyst Brandt Montour tells investors to stay long shares of Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) given the companies' "depressed" valuations. The analyst is positive on Cruise shares in 2019 as he sees "strong/stable" fundamentals. The stocks can outperform from here as operators continue to execute modest organic pricing/net yield growth and low-teens earnings growth, says the analyst. He keeps Overweight ratings on Royal and Norwegian and a Neutral rating on Carnival (CCL).

RCL

Royal Caribbean

$104.31

0.42 (0.40%)

NCLH

Norwegian Cruise Line

$45.72

0.72 (1.60%)

CCL

Carnival

$51.98

0.09 (0.17%)

  • 11

    Jan

  • 28

    May

RCL Royal Caribbean
$104.31

0.42 (0.40%)

10/11/18
JPMS
10/11/18
NO CHANGE
JPMS
JPMorgan recommends staying long shares of Royal Caribbean
JPMorgan shifted lead coverage of Carnival (CCL), Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) to analyst Brandt Montour. Operating fundamentals in the cruise space remain intact outside of parts of the Caribbean, and while the stocks have rebounded materially from Q2 lows, sentiment does not seem bullish, Montour tells investors in a research note. He recommends staying long top pick Royal Caribbean, as all of his checks indicate the company has the most momentum on 2019 pricing and is "valued attractively on a price to growth ratio." Montour also keeps an Overweight rating on Norwegian Cruise and a Neutral rating on Carnival, where he wants to see a rebound in the Caribbean before getting more constructive on the shares.
10/29/18
WELS
10/29/18
NO CHANGE
Target $145
WELS
Outperform
Royal Caribbean price target lowered to $145 form $150 at Wells Fargo
Wells Fargo analyst Timothy Conder lowered his price target for Royal Caribbean to $145 form $150 on revised 2019 estimates. The analyst reiterates an Outperform rating on the shares and says remains buyers on strong secular demand trends, better collective operating and financial management, and negligible direct trade risk.
11/30/18
STFL
11/30/18
NO CHANGE
Target $157
STFL
Buy
Royal Caribbean shares remain undervalued, says Stifel
After attending an event with Royal Caribbean upper management and members of the travel agent community that was hosted aboard Celebrity Edge, the first new build for the Celebrity brand in over six years, Stifel analyst Steven Wieczynski said he came away with the drivers of his constructive thesis "firmly intact" and he continues to view the shares as undervalued. Echoing what they said during their Q3 call, Royal Caribbean management noted that the company is in a stronger booked position for 2019 than it was in at the same time last year for 2018, noted Wieczynski, who reiterates a Buy rating and $157 price target on the stock.
12/21/18
LEHM
12/21/18
NO CHANGE
LEHM
Overweight
Barclays a buyer of Royal Caribbean, Norwegian after yesterday's selloff
Barclays analyst Felicia Hendrix is a buyer of Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) following yesterday's selloff. Carnival's earnings call yesterday took down all three cruise stocks by "injecting uncertainty regarding Europe into the narrative," Hendrix tells investors in a research note. The analyst acknowledges that there will now be an overhang on the entire group until it becomes clear that this is a Carnival-specific issue. However, it is important to understand that Carnival's strategy in Europe has been operating country-specific brands that source from very specific markets, says Hendrix. The analyst points out that in contrast, Royal Caribbean and Norwegian's brands are globally sourced and marketed, allowing them to fill their ships with customers that will pay the most from anywhere in the world.
NCLH Norwegian Cruise Line
$45.72

0.72 (1.60%)

01/08/19
BERN
01/08/19
UPGRADE
BERN
Outperform
Norwegian Cruise Line upgraded to Outperform from Market Perform at Bernstein
12/26/18
WEDB
12/26/18
NO CHANGE
Target $65
WEDB
Outperform
Norwegian Cruise Line removed from Best Ideas list at Wedbush
Wedbush removed Norwegian Cruise Line from the Best Ideas list due to its investment price discipline. The firm has an Outperform rating and $65 price target on the shares.
01/08/19
01/08/19
UPGRADE
Target $57

Outperform
Norwegian Cruise Line upgraded to Outperform at Bernstein
As previously reported, Bernstein analyst David Beckel upgraded Norwegian Cruise Line to Outperform from Market Perform, with a $57 price target, to reflect a positive shift in his view of the company's prospects. The analyst also believes the recent capitulation in Cruise sector valuations presents a compelling risk/reward opportunity and a cheap option on a reversal in cycle sentiment.
CCL Carnival
$51.98

0.09 (0.17%)

12/26/18
STPT
12/26/18
INITIATION
STPT
Accumulate
Carnival initiated with an Accumulate at Standpoint Research
Standpoint Research analyst Ronnie Moas initiated Carnival with an Accumulate rating.
12/21/18
DBAB
12/21/18
NO CHANGE
Target $60
DBAB
Hold
Carnival price target lowered to $60 from $65 at Deutsche Bank
Deutsche Bank analyst Chris Woronka lowered his price target for Carnival to $60 saying current market sentiment "might be too tough to help the stock rebound in the near term." The analyst keeps a Hold rating on the shares after the company offered softer than expected fiscal 2019 yield guidance.
12/21/18
RHCO
12/21/18
NO CHANGE
Target $67
RHCO
Buy
Carnival price target lowered to $67 from $77 at SunTrust
SunTrust analyst C. Patrick Scholes lowered his target PE multiple for Carnival to stay in keeping with the S&P 500 and cut his price target on the stock to $67 from $77 following the company's Q4 results, stating that while the company's guidance is likely conservative that supply growth in Europe is diluting demand. He keeps a Buy rating on Carnival, but says the stock will likely be range-bound until next earnings.

TODAY'S FREE FLY STORIES

LMFA

LM Funding

$2.19

0.765 (53.87%)

12:27
01/17/19
01/17
12:27
01/17/19
12:27
Hot Stocks
LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019 »

Earlier on Thursday, LM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWSA

News Corp.

$12.42

0.03 (0.24%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Upgrade
News Corp. rating change  »

News Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$22.17

0.9 (4.23%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Options
First Data call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BLK

BlackRock

$410.20

-2.65 (-0.64%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Periodicals
BlackRock CEO calls on business leaders to tackle social issues, FT says »

BlackRock CEO Larry Fink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

, AAPL

Apple

$154.13

-0.75 (-0.48%)

12:22
01/17/19
01/17
12:22
01/17/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

AAPL

Apple

$154.13

-0.75 (-0.48%)

JNJ

Johnson & Johnson

$128.65

0.65 (0.51%)

SHLD

Sears

$0.00

(0.00%)

SBNY

Signature Bank

$120.40

7.98 (7.10%)

MTB

M&T Bank

$161.77

7.32 (4.74%)

SIG

Signet Jewelers

$25.63

-7.745 (-23.21%)

WDC

Western Digital

$35.97

-1.83 (-4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 29

    Jan

  • 07

    Feb

  • 18

    Feb

LPCN

Lipocine

$2.24

0.65 (40.88%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Recommendations
Lipocine analyst commentary  »

Ladenburg reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$5.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Hot Stocks
Limbach awarded contracts totaling $81.4M for hospital construction »

Limbach Holdings provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$2.27

0.68 (42.77%)

12:12
01/17/19
01/17
12:12
01/17/19
12:12
Periodicals
Lipocine NASH data contain plenty of 'red flags,' STAT's Feuerstein writes »

This morning's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$7.79

-0.19 (-2.38%)

12:10
01/17/19
01/17
12:10
01/17/19
12:10
Options
Second day of call buying in Cenovus Energy continues as shares slump »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.79

2.9 (4.40%)

12:04
01/17/19
01/17
12:04
01/17/19
12:04
Hot Stocks
Square launches free debit card for business, with sellers access to funds »

Square announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

ALBO

Albireo Pharma

$24.54

0.08 (0.33%)

12:03
01/17/19
01/17
12:03
01/17/19
12:03
Hot Stocks
Albireo Pharma treatment of biliary atresia granted FDA orphan status »

Albireo Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$8.67

-0.23 (-2.58%)

12:02
01/17/19
01/17
12:02
01/17/19
12:02
Hot Stocks
Gulfport Energy confirms receipt of Firefly letter »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$13.09

-2.32 (-15.06%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
United Natural Foods falls -15.1% »

United Natural Foods is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$5.28

-1.49 (-22.01%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Earthstone Energy falls -21.9% »

Earthstone Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$25.49

-7.885 (-23.63%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Signet Jewelers falls -23.6% »

Signet Jewelers is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$27.64

2.27 (8.95%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Skechers rises 9.2% »

Skechers is up 9.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSV

Carriage Services

$18.60

1.61 (9.48%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Carriage Services rises 9.6% »

Carriage Services is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SNH

Senior Housing

$12.82

-0.07 (-0.54%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Options
Put buyers in Senior Housing Properties »

Put buyers in Senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.00

(0.00%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Sears confirms ESL selected as winning bidder in bankruptcy auction »

Sears Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OZM

Och-Ziff Capital

$12.51

1.27 (11.30%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Och-Ziff Capital rises 11.1% »

Och-Ziff Capital is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$68.66

0.78 (1.15%)

, PLCE

Children's Place

$87.83

2.66 (3.12%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Periodicals
Target revamps its baby line Cloud Island to include essential items, CNBC says »

With the demise of …

TGT

Target

$68.66

0.78 (1.15%)

PLCE

Children's Place

$87.83

2.66 (3.12%)

CRI

Carter's

$78.68

0.48 (0.61%)

GPS

Gap

$25.28

0.38 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.90

0.1 (0.46%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Recommendations
Emergent BioSolutions, Amphastar analyst commentary  »

Wells says naloxone news…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.90

0.1 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.91

0.11 (0.50%)

11:55
01/17/19
01/17
11:55
01/17/19
11:55
Hot Stocks
FDA commissioner describes efforts to support development of OTC naloxone »

FDA Commissioner Scott…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.91

0.11 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.